These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 6205601)
1. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Lloyd RV; Mervak T; Schmidt K; Warner TF; Wilson BS Am J Surg Pathol; 1984 Aug; 8(8):607-14. PubMed ID: 6205601 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of pancreatic islet cell tumors in the ferret (Mustela putorius furo). Andrews GA; Myers NC; Chard-Bergstrom C Vet Pathol; 1997 Sep; 34(5):387-93. PubMed ID: 9381649 [TBL] [Abstract][Full Text] [Related]
3. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats. Myers NC; Andrews GA; Chard-Bergstrom C Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968 [TBL] [Abstract][Full Text] [Related]
4. Synaptophysin. A new marker for pancreatic neuroendocrine tumors. Chejfec G; Falkmer S; Grimelius L; Jacobsson B; Rodensjö M; Wiedenmann B; Franke WW; Lee I; Gould VE Am J Surg Pathol; 1987 Apr; 11(4):241-7. PubMed ID: 3032010 [TBL] [Abstract][Full Text] [Related]
5. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors. Nash SV; Said JW Am J Clin Pathol; 1986 Oct; 86(4):415-22. PubMed ID: 2429541 [TBL] [Abstract][Full Text] [Related]
6. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Lloyd RV; Cano M; Rosa P; Hille A; Huttner WB Am J Pathol; 1988 Feb; 130(2):296-304. PubMed ID: 3341449 [TBL] [Abstract][Full Text] [Related]
7. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast. Bussolati G; Gugliotta P; Sapino A; Eusebi V; Lloyd RV Am J Pathol; 1985 Aug; 120(2):186-92. PubMed ID: 4025508 [TBL] [Abstract][Full Text] [Related]
8. Localization of chromogranin A-immunoreactivity in bovine gastrointestinal endocrine cells with special reference to Grimelius silver stain. Kawakita S; Takatsuki K; Tsukada M; Yoneda M; Takano T; Kawakubo A; Nagura H Endocrinol Jpn; 1990 Apr; 37(2):299-308. PubMed ID: 1699753 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids. Srivastava A; Padilla O; Fischer-Colbrie R; Tischler AS; Dayal Y Am J Surg Pathol; 2004 Oct; 28(10):1371-8. PubMed ID: 15371954 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Yantiss RK; Chang HK; Farraye FA; Compton CC; Odze RD Am J Surg Pathol; 2002 Jul; 26(7):893-901. PubMed ID: 12131156 [TBL] [Abstract][Full Text] [Related]
11. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Said JW; Vimadalal S; Nash G; Shintaku IP; Heusser RC; Sassoon AF; Lloyd RV Hum Pathol; 1985 Mar; 16(3):236-40. PubMed ID: 3972403 [TBL] [Abstract][Full Text] [Related]
12. Chromogranin A immunoreactivity and Grimelius' argyrophilia. A correlative study in mammalian endocrine cells. Cetin Y Anat Embryol (Berl); 1992; 185(3):207-15. PubMed ID: 1349463 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase. Seshi B; True L; Carter D; Rosai J Am J Pathol; 1988 May; 131(2):258-69. PubMed ID: 3282444 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors. Tomita T Islets; 2011; 3(6):344-51. PubMed ID: 21983096 [TBL] [Abstract][Full Text] [Related]
15. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024 [TBL] [Abstract][Full Text] [Related]
16. Transthyretin in endocrine pancreatic tumors. Jacobsson B; Carlström A; Collins VP; Grimelius L Am J Pathol; 1989 Feb; 134(2):465-71. PubMed ID: 2464944 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours. Bordi C; Pilato FP; D'Adda T Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642 [TBL] [Abstract][Full Text] [Related]
18. Calponin is expressed in serous cystadenomas of the pancreas but not in adenocarcinomas or endocrine tumors. Marsh WL; Colonna J; Yearsley M; Bloomston M; Frankel WL Appl Immunohistochem Mol Morphol; 2009 May; 17(3):216-9. PubMed ID: 19391217 [TBL] [Abstract][Full Text] [Related]
19. A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours. Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E Acta Endocrinol (Copenh); 1990 Feb; 122(2):145-55. PubMed ID: 2316306 [TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers. Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]